These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2719845)

  • 21. Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally retarded persons.
    Glaser BA; Morreau LE
    Am J Ment Defic; 1986 Jan; 90(4):371-9. PubMed ID: 3946474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.
    Aman MG; Sarphare G; Burrow WH
    Am J Ment Retard; 1995 Mar; 99(5):500-9. PubMed ID: 7779345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of states' practices on the use of psychotropic medication.
    Rinck C; Guidry J; Calkins CF
    Am J Ment Retard; 1989 May; 93(6):657-68. PubMed ID: 2719848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Issues in psychopharmacology with the mentally retarded.
    Mouchka S
    Psychopharmacol Bull; 1985; 21(2):262-7. PubMed ID: 4001290
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior problems in adults with mental retardation. Psychopharmaceuticals are used too often--pedagogical efforts would be better].
    Näslund I
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1132-5. PubMed ID: 17472101
    [No Abstract]   [Full Text] [Related]  

  • 27. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons.
    Inoue F
    Ment Retard; 1982 Apr; 20(2):70-4. PubMed ID: 7078402
    [No Abstract]   [Full Text] [Related]  

  • 28. Buspirone for autistic disorder in a woman with an intellectual disability.
    Brahm NC; Fast GA; Brown RC
    Ann Pharmacother; 2008 Jan; 42(1):131-7. PubMed ID: 18056831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot study on the use of psychotropic medication in persons with mental retardation.
    Radouco-Thomas M; Bolduc M; Brisson A; Brassard P; Fortier L; Thivierge J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):879-83. PubMed ID: 15363610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication and programming in controlling the behavior of mentally retarded individuals in community settings.
    Schalock RL; Foley JW; Toulouse A; Stark JA
    Am J Ment Defic; 1985 Mar; 89(5):503-9. PubMed ID: 2859807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trimonam and mental retardation.
    Huston I; Swett C; Cole JO
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):70-2. PubMed ID: 401715
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of psychotropic drugs on intelligence test performance of institutionalized mentally retarded adults.
    Breuning SE; Davidson NA
    Am J Ment Defic; 1981 May; 85(6):575-9. PubMed ID: 6791499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical observations on the anticonvulsant and psychotropic activity of carbamazepine].
    Visentin B; Mattiuzzi D; Galvagni V
    Riv Neurol; 1971; 41(1):18-33. PubMed ID: 4999081
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities.
    Branford D
    J Intellect Disabil Res; 1996 Aug; 40 ( Pt 4)():322-9. PubMed ID: 8884587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral correlates of levels of intelligence.
    Ross RT
    Am J Ment Defic; 1972 Mar; 76(5):545-9. PubMed ID: 4258927
    [No Abstract]   [Full Text] [Related]  

  • 38. Abuse-provoking characteristics of institutionalized mentally retarded individuals.
    Rusch RG; Hall JC; Griffin HC
    Am J Ment Defic; 1986 May; 90(6):618-24. PubMed ID: 3717218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of psychotropic drugs in mentally handicapped adults].
    Meins W
    Psychiatr Prax; 1988 Nov; 15(6):218-22. PubMed ID: 3237896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Client characteristics and residential placement patterns.
    Borthwick-Duffy SA; Eyman RK; White JF
    Am J Ment Defic; 1987 Jul; 92(1):24-30. PubMed ID: 3618655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.